A carregar...
Treatment of pancreatic cancer—neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is currently ranked fourth place of cancer related mortality. Only a minority of 10–20% of patients with PDAC have a primarily resectable disease, while 50–60% of the patients are diagnosed with irresectable disease. A certain group of patients is defined as “...
Na minha lista:
| Publicado no: | Transl Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556697/ https://ncbi.nlm.nih.gov/pubmed/31231699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2019.04.09 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|